2021 Annual General Meeting & 2020 Annual Report

Due to COVID-19 safety precautions, the Newfoundland and Labrador Pharmacy Board’s Annual General Meeting will take place online via Zoom again this year. The meeting is open to all registrants, so if you would like to join, please mark your calendars for Friday, August 6, 2021, 9:30am-10:30am. The meeting link will be sent to all registrants at least one week prior to the AGM.

Agenda:

  1. Call to Order and Adoption of Agenda
  2. Introduction of Board Members
  3. Minute of Silence in Memoriam
  4. Highlights of 2020 Annual Report
  5. Questions on Annual Report
  6. Appointment of Auditor for 2022
  7. Board Member Election Results
  8. Recognition of Outgoing Board Members
  9. Inauguration of Incoming Chair
  10. Recognition of Outgoing Chair
  11. Adjournment
The 2020 Annual Report is now available for viewing online at: https://nlpb.ca/media/Annual-Report-2020.pdf

 

Requirements for Hiring Relief Pharmacists

Pharmacists in Charge looking to hire relief pharmacists are reminded that prospective pharmacist applicants, including those registered in other provinces, must fulfill all requirements of registration in NL, including providing proof of professional liability insurance, a current certificate of conduct, PANL membership, successful completion of NLPB’s Registration Examination, verification of hours from current employer, and a letter of standing from their provincial regulatory authority. Please view the appropriate registration interpretation guide on NLPB’s website for more information.

Please note that the registration process, following the opening of a file, requires a minimum of 4-6 weeks to complete. “Locum” registration is not available in Newfoundland and Labrador under the provincial legislation.

 

Extension of Health Canada Subsection 56 (1) Class Exemption for Patients, Pharmacists Prescribing and Providing Controlled Substances in Newfoundland and Labrador

In March 2020, Health Canada issued an exemption for certain provisions of the Controlled Drugs Act (CDSA) and its regulations, in light of the COVID-19 pandemic. The current exemption is set to expire on September 30, 2021.

Health Canada has recently authorized a five-year extension of this subsection 56 (1) class exemption from the CDSA, which will be effective October 1, 2021 to September 30, 2026, or until such time as it is replaced by another exemption or revoked.

This exemption provides practitioners with the authority to issue a verbal prescription for controlled substances.

This exemption provides pharmacists with the authority to transfer a prescription for a controlled substance, and to prescribe, sell, or provide a controlled substance to patients subject to the terms and conditions of the exemption.

Pharmacists acting under the authority of this exemption must:

  1. Only prescribe, sell, provide, or transfer the controlled substance to a patient while that patient is under their professional treatment;
  2. Only prescribe, sell, provide, or transfer a controlled substance to a patient in order to extend or renew an existing prescription;
  3. Only prescribe a controlled substance to a patient in accordance with any policies and/or guidelines established by the provincial or territorial government and by any relevant provincial or territorial licensing authorities;
  4. Comply with a record keeping obligations established by the provincial or territorial government and any relevant provincial or territorial licensing authority regarding all transactions involving controlled substances;
  5. If not already required pursuant to item 4, keep records of the following:
    • the name and address of any patient who is prescribed, sold, or provided a controlled substance under this exemption;
    • the name, quantity, and form of the controlled substance prescribed;
    • the name or initials of the pharmacist who prescribed, sold, or provided the controlled substance;
    • the date on which the controlled substance was prescribed, sold, or provided; and
    • the number assigned to the prescription.
  6. With respect to the transfer of a prescription, keep records of the following:
    • a copy of the prescription written by the practitioner or the record made in accordance with the practitioner’s verbal prescription;
    • the name and business address of the transferring pharmacist;
    • the name and business address of the pharmacist receiving the prescription transfer;
    • the number of authorized refills remaining and, if applicable, the specified interval between refills; and
    • the date of the last refill.
  7. All records should be kept in the pharmacy for a period of two years from the date that each record is made.

Maintaining Authorization to Administer Injections

Pharmacists are reminded that once a pharmacist is authorized to administer drug therapy by inhalation or injection, the pharmacist must:

  • administer inhalations and injections only in accordance with provincial guidelines, standards by NLPB, and within the limits of the pharmacists’ own competence;
  • maintain competence and skill level in administering inhalations and injections;
  • maintain appropriate CPR and First Aid certification; and
  • complete a professional declaration annually at renewal, indicating that they have taken action to comply with the requirements of this section. If this declaration cannot be made, remedial training, such as a refresher program, may be required.

In the past, NLPB has advised pharmacists seeking information about the annual professional declaration to register for and complete a formal refresher training program through an accredited provider. Unfortunately, as pharmacists have begun to administer injections more regularly, the need for these programs has waned, resulting in less availability of such programs. As such, we now advise pharmacists to:

  • ensure clinical competency by participating in self-study – review the online learning modules, the latest Immunization Guides, and product monographs for the medications/vaccinations that you intend to administer.
  • ensure technical competency by re-completing the live portion of the accredited program, shadowing another pharmacist or health professional, and/or asking that pharmacist or health professional to observe your technique and offer feedback.

If you let your authorization to administer injections lapse, reapply by completing and submitting the Application for Authorization.

It is ultimately up to the pharmacist to ensure that they are clinically and technically competent and, if not, refrain from offering the service until such time as they are able to address the deficiency.

 

Consultation on National Principles of Professionalism for Pharmacy

Professionalism is a fundamental component in the delivery of quality healthcare. Recognizing the importance of a strong culture of professionalism, the National Association of Pharmacy Regulatory Authorities (NAPRA), along with pharmacy professionals and pharmacy stakeholders, has developed eight principles of professionalism.

These principles, applicable to all who work and contribute to the profession of pharmacy, represent the first steps towards enhancing the culture of professionalism in pharmacy practice. A comprehensive paper on the topic of the culture of professionalism in pharmacy has been written and is available for background reading.

NAPRA invites all pharmacy professionals, pharmacy stakeholders, and members of the public to provide feedback on the draft Principles of Professionalism. We invite you to share these documents as widely as possible.

The consultation process will be open between June 4, 2021 and August 3, 2021.

We invite you to provide feedback using the following link: FEEDBACK FORM

Questions about the consultation process can be directed to professionalism@napra.ca.

We sincerely appreciate your input on this important topic.

 

 

Regular reminders

  • Registrant Contact Information – Registrants are responsible for ensuring that the contact information on their registrant profile, including email address and practice site, is accurate at all times. The NLPB primarily uses email communication to send newsletters, renewal reminders, practice site assessment information, professional development audit information, calls for interest for committees, and other alerts. If the email address on file is incorrect, important information may be missed and/or disclosed to the wrong person. If your contact information changes, please log into the NLPB Online Registrant Portal to update your file with your new contact information as soon as you can.
  • Forgot Your Password? – You can retrieve your NLPB Online Registrant Portal password at any time. Under the Login box, click the message that says, “Forgot your password? Click here to restore it.” On the next screen, enter your NLPB username, if you know it, or your email address. Click “Retrieve.” In a few minutes, you will receive an email with your username and password. Once you are logged into your profile, you can change your password.
  • Receipts & Invoices – NLPB’s Online Registrant Portal maintains all receipts created by the system. If for any reason, you need a receipt or to view an invoice, you can do so from your registrant profile. Once logged in, click on “Renewal Other/Invoices” and then select either “view invoice” or “print invoice” next to the one you are interested in.

 

This e-newsletter contains information on a wide variety of topics intended to enhance the practice of pharmacy in the province of Newfoundland and Labrador. As it is published and circulated to all registrants on a monthly basis, it is the expectation of NLPB that all registrants are aware of the matters contained therein.



©2021 Newfoundland & Labrador Pharmacy Board